In another study done with 3,792 Covid patients from around the world, 7 months after contracting the illness, 78% reported fatigue, 57% reported cognitive dysfunction, and 68% were still unable to work
Descarga la ltima versin de nuestra app y actvalas para no perderte nuestro mejor contenido.
The FDA's announcement on February 21, 2025, declared the Semaglutide shortage resolved, triggering new restrictions on compounding (FDA Clarifies Policies for Compounders)
UK prescribers and patients now have substantial real-world experience with titration, injection technique, missed-dose rules, and follow-up, alongside the SURPASS trial programme that supported licensing